AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27350258.
- Also identified by DOI 10.7554/eLife.12414 and PMC identifier 4924996.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The receptor tyrosine kinase (RTK) AXL is induced in response to type I interferons (IFNs) and limits their production through a negative feedback loop. Enhanced production of type I IFNs in Axl(-/-) dendritic cells (DCs) in vitro have led to speculation that inhibition of AXL would promote antiviral responses. Notwithstanding, type I IFNs also exert potent immunosuppressive functions. Here we demonstrate that ablation of AXL enhances the susceptibility to infection by influenza A virus and West Nile virus. The increased type I IFN response in Axl(-/-) mice was associated with diminished DC maturation, reduced production of IL-1β, and defective antiviral T cell immunity. Blockade of type I IFN receptor or administration of IL-1β to Axl(-/-) mice restored the antiviral adaptive response and control of infection. Our results demonstrate that AXL is essential for limiting the immunosuppressive effects of type I IFNs and enabling the induction of protective antiviral adaptive immunity.
Medical subject headings
- Influenza A virus
- Lymphocyte Activation
- Proto-Oncogene Proteins
- Receptor Protein-Tyrosine Kinases
- T-Lymphocytes
- West Nile virus